Related Experiment Video
Updated: Jul 10, 2026
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
Glanders: off to the races with Burkholderia mallei
Gregory C Whitlock1, D Mark Estes, Alfredo G Torres
1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-1070, USA.
Abstract:
Burkholderia mallei, the etiologic agent of the disease known as glanders, is primarily a disease affecting horses and is transmitted to humans by direct contact with infected animals. The use of B. mallei as a biological weapon has been reported and currently, there is no vaccine available for either humans or animals. Despite the history and highly infective nature of B. mallei, as well as its potential use as a bio-weapon, B. mallei research to understand the pathogenesis and the host responses to infection remains limited. Therefore, this minireview will focus on current efforts to elucidate B. mallei virulence, the associated host immune responses elicited during infection and discuss the feasibility of vaccine development.
Insights
Burkholderia mallei causes glanders, a disease affecting horses and humans. Research is limited on its virulence and host response, highlighting the need for a vaccine against this potential bioweapon.
Area of Science:
- Microbiology
- Immunology
- Veterinary Medicine
Background:
- Burkholderia mallei is the bacterium responsible for glanders, a significant disease in equids with zoonotic potential.
- Glanders poses a threat due to its high infectivity, potential for human transmission, and documented use as a biological weapon.
- Limited research exists on Burkholderia mallei pathogenesis and host immune responses, despite its historical significance and bioweapon potential.
Purpose of the Study:
- To review current research efforts focused on understanding Burkholderia mallei virulence factors.
- To elucidate the host immune responses triggered during glanders infection.
- To assess the feasibility of developing a vaccine against Burkholderia mallei for both animal and human use.
Main Methods:
- Literature review of existing studies on Burkholderia mallei.
- Analysis of research on bacterial pathogenesis and virulence mechanisms.
- Examination of host-pathogen interactions and immune system responses.
- Evaluation of current vaccine development strategies and challenges.
Main Results:
- Current understanding of Burkholderia mallei virulence remains incomplete.
- Specific host immune responses to B. mallei infection are not fully characterized.
- No effective vaccine is currently available for glanders in humans or animals.
Conclusions:
- Further research is crucial to fully understand Burkholderia mallei pathogenesis and host immunity.
- Developing a safe and effective vaccine for glanders is a critical unmet need.
- Addressing knowledge gaps in B. mallei biology is essential for biodefense and public health.
